Il Dong Pharmaceutical Co Ltd (249420) — Free Cash Flow Generation Index

Latest as of September 2025: 0.47x

Il Dong Pharmaceutical Co Ltd (249420) has a Free Cash Flow Generation Index of 0.47x as of September 2025. Free cash flow of ₩5.31 Billion represents 0% of operating cash flow (₩11.28 Billion). See Il Dong Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.47x
Free Cash Flow / Operating CF

Free Cash Flow

₩5.31 Billion
KRW

Operating Cash Flow

₩11.28 Billion
KRW

Capital Expenditures

₩5.97 Billion
KRW

Il Dong Pharmaceutical Co Ltd Free Cash Flow Generation Index (2016–2024)

Historical FCF Generation Index trend for Il Dong Pharmaceutical Co Ltd across 6 annual periods. Explore 249420 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Il Dong Pharmaceutical Co Ltd (2016–2024)

Year-by-year Free Cash Flow Generation Index for Il Dong Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Il Dong Pharmaceutical Co Ltd market cap and net worth.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 0.50x ₩14.24 Billion ₩28.29 Billion ₩14.05 Billion ▲ +5983.5%
2020 0.01x ₩160.22 Million ₩19.37 Billion ₩14.35 Billion ▼ -98.4%
2019 0.53x ₩22.01 Billion ₩41.37 Billion ₩12.06 Billion ▼ -22.7%
2018 0.69x ₩45.86 Billion ₩66.65 Billion ₩15.09 Billion ▲ +75.7%
2017 0.39x ₩28.88 Billion ₩73.72 Billion ₩16.73 Billion ▼ -70.1%
2016 1.31x ₩60.20 Billion ₩45.98 Billion ₩14.22 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).